stockportfolio.pro
Stocks / ITGR vs TLX
ITGR vs TLX
Integer Holdings Corporation and Telix Pharmaceuticals Limited side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Integer Holdings Corporation (ITGR) | Telix Pharmaceuticals Limited (TLX) | |
|---|---|---|
| Market cap | $3.1B | $3.2B |
| Revenue (latest FY) | $1.85B | $803.79M |
| Net income (latest FY) | $102.81M | $-7.13M |
| Revenue growth (5y CAGR) | 11.5% | 94.7% |
| Net margin | 5.5% | -0.9% |
| Return on equity | 5.9% | -1.7% |
| P/E ratio | 22.9 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 2 |
| Positive free cash flow | Yes | — |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ITGR — free Open TLX — freeFrequently asked questions
Which is bigger, ITGR or TLX?
Telix Pharmaceuticals Limited is larger by market capitalization — $3.2B versus $3.1B.
Which grows faster, ITGR or TLX?
Over the last five fiscal years, Telix Pharmaceuticals Limited grew revenue faster — 94.7%/yr versus 11.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.